P2RX7 and Alzheimer disease: While further studies in AD are essential to validate these findings, it is conceivable that in our study, the weaker upregulated expression of P2X7 receptor compared to P2Y12 receptor in the APP/PS1-21 mouse model may be attributed to the predominantly anti-inflammatory microglial activation status.